Literature DB >> 1322188

Prevention of viral infections after bone marrow transplantation.

U Schuler1, G Ehninger.   

Abstract

After bone marrow transplantation, a number of viral infections contribute to the morbidity and mortality of the procedure. Established preventive measures to avoid primary infection and reactivation of herpes-and cytomegaloviruses are outlined. Possible future strategies against these viruses (e. g., monoclonal antibodies, transfer of T-lymphocytes) and the possible role of improved diagnostic tools are briefly discussed.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1322188     DOI： 10.1007/bf01715371

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


  65 in total

1.  Phase I study of safety and pharmacokinetics of a human anticytomegalovirus monoclonal antibody in allogeneic bone marrow transplant recipients.

Authors:  W R Drobyski; M Gottlieb; D Carrigan; L Ostberg; M Grebenau; H Schran; P Magid; P Ehrlich; P I Nadler; R C Ash
Journal:  Transplantation       Date:  1991-06       Impact factor: 4.939

2.  Human monoclonal antibodies neutralizing cytomegalovirus (CMV) for prophylaxis of CMV disease: report of a phase I trial in bone marrow transplant recipients.

Authors:  W E Aulitzky; T F Schulz; H Tilg; D Niederwieser; K Larcher; L Ostberg; M Scriba; J Martindale; A C Stern; P Grass
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

3.  [Oral prophylaxis of herpes infections using acyclovir following bone marrow transplantation: a clinical and clinico-pharmacological study].

Authors:  G Ehninger; A Vallbracht; K Schüch; I Kumbier; R Dopfer; H Schmidt; P Ostendorf
Journal:  Klin Wochenschr       Date:  1986-06-16

4.  Hepatitis B virus (HBV) infection and liver disease after allogeneic bone marrow transplantation: a report of 30 cases.

Authors:  A Locasciulli; A Bacigalupo; M T Van Lint; L Chemello; P Pontisso; D Occhini; C Uderzo; H M Shulman; B Portmann; A M Marmont
Journal:  Bone Marrow Transplant       Date:  1990-07       Impact factor: 5.483

5.  Risk factors for cytomegalovirus infection after human marrow transplantation.

Authors:  J D Meyers; N Flournoy; E D Thomas
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

6.  The importance of pre bone marrow transplantation serology in determining subsequent cytomegalovirus infection. An analysis of risk factors.

Authors:  T Paulin; O Ringdén; B Lönnqvist; B Wahren; B Nilsson
Journal:  Scand J Infect Dis       Date:  1986

7.  The influence of T cell depletion on recovery of T cell proliferation to herpesviruses and Candida after allogeneic bone marrow transplantation.

Authors:  G C de Gast; J W Gratama; L F Verdonck; J G van Heugten; F E Zwaan; D I Phillips; G C Mudde
Journal:  Transplantation       Date:  1989-07       Impact factor: 4.939

8.  Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation.

Authors:  J C Wade; B Newton; N Flournoy; J D Meyers
Journal:  Ann Intern Med       Date:  1984-06       Impact factor: 25.391

9.  Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant.

Authors:  J D Meyers; N Flournoy; E D Thomas
Journal:  J Infect Dis       Date:  1980-12       Impact factor: 5.226

10.  Acyclovir prophylaxis of herpes-simplex-virus infections.

Authors:  R Saral; W H Burns; O L Laskin; G W Santos; P S Lietman
Journal:  N Engl J Med       Date:  1981-07-09       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.